Risk assessment-based control strategy for residual solvents in chemical drugsHUANG Chao-yu, YAN Fei, YAO Zhi-yu, SHAO Fang-xiang, LI Rui, WANG Yu1-5
AQbD-based analysis and case studies:interpretation of Chinese Pharmacopoeia and ICH Q2 analytical procedure validation guidelinesSHAO Fang-xian, HUANG Chao-yu, YAN Fei, WANG Yu, LI Rui6-10
Construction and application evaluation of clinical trial quality management system based on artificial intelligenceZHAO Shi-jie, WANG Ting, ZHENG Jing, WANG Zheng, XIE Meng, LIANG Jing, YU Hang, ZHANG Xu-dong11-16
Study on the simplified registration pathway for over-the-counter traditional Chinese medicinesMO Qi-hui, LI Ze-yu, LI Yuan-heng, ZHANG Lu-na, DONG Chen-dong, WANG Yong, YANG Yue17-23
Research on the application of big data in distribution of national drug reference standardsGAO Zhi-feng, LUO Chen, AN Ran, ZHAO Zong-ge, WU Xian-fu, YANG Hui-ying24-27
Research on the influence of artificial intelligence technology on innovation efficiency of pharmaceutical manufacturing industryZHANG Wen-lin, WANG Shu-ling28-34
A perspective from generic drugs on typical cases under China's drug patent linkage systemSONG Jie-mei, WANG Hua-ping, XU Dan35-40
The impact of drug transporter polymorphisms on anti-cancer drug dispositionTIAN Guan-fang, YANG Zi-wei, CHEN Yue-wen, WANG Xiao-liang, WANG Ze41-45
Research advances on iridoids of Eucommia ulmoides Oliv.ZHANG Bao-jun, HONG Yan-long, ZHANG Lei, WANG Jian-ying46-54
Mechanism and clinical evaluation of a novel drug deuruxolitinib for treatment of alopecia areataQIAN Qing, DU Wen-lin, WANG Qiang55-58